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Adhesin-mediated binding to extracellular matrix (ECM) proteins is thought to be a crucial step in the
pathogenic process of many bacterial infections. We have previously reported conditional adherence of most
Enterococcus faecalis isolates, after growth at 46°C, to ECM proteins collagen types I and IV and laminin;
identified an E. faecalis-specific gene, ace, whose encoded protein has characteristics of a bacterial adhesin; and
implicated Ace in binding to collagen type I. In this study, we constructed an ace disruption mutant from
E. faecalis strain OG1RF that showed marked reduction in adherence to collagen types I and IV and laminin
when compared to the parental OG1RF strain after growth at 46°C. Polyclonal immune serum raised against
the OG1RF-derived recombinant Ace A domain reacted with a single ;105-kDa band of mutanolysin extracts
from OG1RF grown at 46°C, while no band was detected in extracts from OG1RF grown at 37°C, nor from the
OG1RF ace mutant grown at 37 or 46°C. IgGs purified from the anti-Ace A immune serum inhibited adherence
of 46°C-grown E. faecalis OG1RF to immobilized collagen type IV and laminin as well as collagen type I, at a
concentration as low as 1 mg/ml, and also inhibited the 46°C-evoked adherence of two clinical isolates tested.
We also showed in vitro interaction of collagen type IV with Ace from OG1RF mutanolysin extracts on a
far-Western blot. Binding of recombinant Ace A to immobilized collagen types I and IV and laminin was
demonstrated in an enzyme-linked immunosorbent assay and was shown to be concentration dependent. These
results indicate that Ace A mediates the conditional binding of E. faecalis OG1RF to collagen type IV and
laminin in addition to collagen type I.
Collagens, proteoglycans, and structural glycoproteins such
as fibronectin and laminin (LN) are found in the extracellular
matrix (ECM) of all eukaryotic tissues and are frequently ex-
ploited for colonization by microbes and initiation of infections
(5, 13, 38). Collagen contains a characteristic Gly-X-Y repeat-
ing tripeptide sequence, where X and Y often are proline
and hydroxyproline, respectively. Segments of the collagen
polypeptides containing this repeat sequence form character-
istic triple helix structures with a rope-like appearance. In
mammals, collagen occurs in close to 20 genetically different
types, some of which show a tissue-specific distribution. For
example, collagen type IV (CIV) is found exclusively in base-
ment membranes, whereas collagen type I (CI) has a relatively
broad distribution (16). LNs, which also occur in several ge-
netically distinct forms, are composed of three polypeptides
that are partly associated to form a characteristic cross, as
revealed by electron microscopy. In the long arm of the cross,
the three polypeptides form a rope-like structure resembling
that seen in collagen. The LNs are components of the base-
ment membrane, where they contribute to the structural integ-
rity of the tissue and to cell signaling (1, 2, 6, 40).
In normal tissues, most ECMs are covered by epithelial or
endothelial cells and hence are not available for binding. How-
ever, any type of trauma that damages host tissues may expose
the ECM and allow microbial colonization and infection. Dur-
ing the past decade, several microorganisms, including strep-
tococci and staphylococci, have been shown to express surface
components that recognize ECM molecules, including collagen
and LN (5, 12–15, 20, 30, 31, 33–35).
Our earlier investigations on adherence of clinical isolates of
Enterococcus faecalis, regardless of their source, showed that
most isolates displayed conditional binding to CI, CIV, and
mouse LN. The adherence phenotype was termed conditional
because it was observed after growth at 46°C, but not, for most
isolates, after growth at 37°C (39); in these experiments, we
defined adherence as being present if .5% of total labeled
cells were bound to the ECM-coated wells. We then identified
a putative collagen binding gene, ace, in the E. faecalis strain
V583 partial database (24), and based on structural similarities
to Cna of Staphylococcus aureus, followed by some biochemical
and biophysical characterization, we assigned a CI binding
function to Ace (24).
In the present investigation, we constructed an E. faecalis
strain OG1RF ace mutant and showed that it is deficient in
adherence to CI, CIV, and LN. We also found that polyclonal
anti-Ace A antibodies raised against recombinant OG1RF-
derived Ace A protein inhibited adherence of wild-type
OG1RF to these three ECM proteins. Using far-Western blots
and solid-phase enzyme-linked immunosorbent assays (ELISAs),
we confirmed in vitro Ace A binding to CI, CIV, and LN.
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MATERIALS AND METHODS
Bacterial strains and culture conditions. The strains and plasmids used in this
study are listed in Table 1. E. faecalis strain OG1RF, a derivative of E. faecalis
OG1, and E. faecalis strain V583 have been described previously (18, 25). E.
faecalis strain MC02152, isolated from a patient with endocarditis, was kindly
provided by J. M. Steckelberg, Mayo Clinic, Minneapolis, Minn. Escherichia coli
cells were grown in Luria-Bertani (LB) broth or on LB agar with appropriate
antibiotics overnight at 37°C. Enterococci were grown either in brain heart
infusion (BHI) broth or agar or in Todd-Hewitt broth or agar (Difco Laborato-
ries, Detroit, Mich.) overnight at 37°C for routine purposes and at 46°C for
adherence assays. Antibiotics were used at the following concentrations: for E.
coli, kanamycin, 50 mg/ml; ampicillin, 50 to 100 mg/ml; for the E. faecalis mutant,
kanamycin, 2,000 mg/ml. All constructs were given TX numbers as shown in
Table 1. Plasmids from these constructs were assigned respective pTEX num-
bers.
Chemicals. CI and CIV were purchased from Sigma Chemical Co. (St. Louis,
Mo.). Mouse LN (isolated from the Engelbreth-Holm-Swarm sarcoma) was
purchased from Life Technologies (Grand Island, N.Y.). Tran35S-label and bo-
vine serum albumin (BSA) were purchased from ICN Biomedicals, Inc. (Costa
Mesa, Calif.). Oligonucleotide primers were purchased from Life Technologies.
PCR buffers were purchased from Invitrogen Corporation (Carlsbad, Calif.). All
other chemicals used in the investigation were of molecular biology grade.
General DNA techniques. DNA preparation, purification, restriction diges-
tion, agarose gel electrophoresis, and ligation were performed by standard meth-
ods (26). Chromosomal DNA from E. faecalis was prepared according to the
method described by Murray and colleagues (18). PCR amplification of DNA
was performed on a DNA thermal cycler (Perkin-Elmer Corp., Norwalk, Conn.).
Preparation of agarose plugs, pulsed-field gel electrophoresis (PFGE), and
Southern blot analysis were carried out according to previously described meth-
ods (17, 22). Radioactive DNA probes were prepared by random-primed labeling
according to the protocol supplied (Life Technologies). Electroporation of E.
coli and E. faecalis was carried out with a Bio-Rad Gene Pulser as described
previously (11). Isopropylthio-b-D-galactoside (IPTG) and 5-bromo-4-chloro-3-
indolyl-b-galactoside (X-Gal) were used at 0.5 mM and 80 mg/ml, respectively.
DNA sequencing reactions were performed by the Taq dye-deoxy terminator
method on an automated ABI Prism sequencer (Applied Biosystems, Foster
City, Calif.).
Construction of a mutation in the ace gene of E. faecalis OG1RF. The E.
faecalis OG1RF ace gene was disrupted by using a suicide vector pTEX4577 (28)
containing an internal fragment of the ace gene. A 1,003-bp internal fragment
(coding for the A domain of Ace of E. faecalis strain OG1RF) was amplified by
PCR with AceF2 (59-GAGCAAAAGTTCAATCGTTGAC-39) and AceR3 (59-
GTCTGTCTTTTCACTTGTTTCT-39) primers and cloned into the TA cloning
vector pCR2.1 (Invitrogen Corp., Carlsbad, Calif.) resulting in TX5252. A
1,100-bp XhoI-KpnI DNA fragment from pTEX5252 was recloned into a pBlue-
script derivative, pTEX4577, and the resulting recombinant plasmid was desig-
nated as pTEX5253. Competent cells of E. faecalis OG1RF were electroporated
with 5 mg of purified pTEX5253 in 2 ml of sterile water (22). Transformants
showing growth on Todd-Hewitt agar supplemented with 2,000 mg of kanamycin
per ml were selected, and one was designated as TX5256. Chromosomal DNA
from agarose plugs was analyzed by PFGE after NotI or SmaI restriction diges-
tion and hybridization to confirm the disruption. To further confirm the location
of pTEX4577 within ace, chromosomal DNA from TX5256 was PCR amplified
with the AceF1 (59-CTATTGTCAACTTCTGAAAAAG-39) primer and T7 or
T3 primers from pTEX4577, and the resulting PCR products were sequenced.
To test for the stability of this disruption mutation, OG1RF ace::pTEX5253
(TX5256) was grown overnight at 37 or 46°C in BHI broth without kanamycin
and then reinoculated into BHI broth, grown again overnight two times, and then
plated on BHI agar. Approximately 3,000 colonies grown on BHI agar were
subpatched on BHI agar supplemented with 2,000 mg of kanamycin per ml to
screen for colonies that had lost resistance to kanamycin.
Adherence assay. Adherence to CI, CIV, and LN was tested by a previously
described assay with some modifications (39). Bacteria were streaked from
freezer vials onto BHI agar and incubated at 37°C overnight. A few colonies were
picked and resuspended in BHI, and 108 CFU were inoculated into 5 ml of BHI
broth with 10 mCi of Tran35S-label per ml. The cultures were grown at 46°C for
16 h and then harvested by centrifugation at 2,800 3 g for 15 min. The cell pellets
were washed three times in phosphate-buffered saline (PBS) buffer and resus-
pended in 0.1% Tween 80–0.1% BSA in PBS. The cell density was adjusted to an
optical density at 600 nm (OD600) of 0.2. One microgram of ECM proteins in a
total volume of 50 ml of PBS was used to coat Immulon 1 Removawells (Dyna-
tech Laboratories, Chantilly, Va.) and incubated at 4°C overnight. After decant-
ing, the wells were blocked with 200 ml of 0.2% BSA in PBS at 4°C for 2 h and
then washed with PBS three times. A total volume of 50 ml of labeled bacteria
was added to each well and incubated at room temperature for 2 h with gentle
shaking at 70 rpm. The wells were washed with 0.1% Tween 80–0.1% BSA in
PBS three times. Each detachable well was separated and placed into a vial with
2 ml of scintillation liquid and counted in a liquid scintillation counter (LKB
Wallace, San Francisco, Calif.). Fifty microliters of labeled bacteria (adjusted to
an OD600 of 0.2) was counted to determine the total amount of radioactivity
added to each well. The percentage of adherence was calculated with the formula
(radioactivity of bound cells/radioactivity of total cells added) 3 100. The assays
were performed in duplicate. Isolates were considered to adhere to ECM pro-
teins if .5% of total labeled cells bound to the well.
Cloning, expression, and purification of Ace A from OG1RF. A 1,008-bp DNA
fragment coding for the complete A domain was amplified from pTEX5252
(derived from OG1RF) by using AceFc (59-CAGAACTCGAGTTGAGCAAA
AGTTCAATC-39) and AceRc (59-TGGAGGTACCCTAGTCTGTCTTTTCAC
TTG-39) primers (introduced restriction sites are underlined) and cloned into
pBAD/HisA expression vector (Invitrogen) followed by electroporation into the
E. coli host LMG194, and one of the resulting colonies (designated as TX5254)
was verified for the fidelity of the sequence and confirmed as correct by sequenc-
ing. Following electrophoresis of lysates on 10% NuPAGE Bis-Tris gels
(NOVEX, San Diego, Calif.), Western transfer was carried out according to the
protocol supplied by NOVEX, and His-tagged recombinant protein was detected
with anti-His (penta) antibodies (Qiagen, Inc., Valencia, Calif.).
The recombinant Ace A domain was overexpressed by inoculating 1 liter of LB
broth with 10 ml of an overnight culture of TX5254. Following 2.5 h of growth
at 37°C, arabinose was added to a final concentration of 0.2% to induce protein
expression, and incubation was continued for an additional 6 h. The bacterial cell
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristicsa Source or reference
Strains
E. faecalis
OG1RF Adh1 Fusr Rifr 18, 39
TX5256 OG1RF ace::pTEX5253; ace insertion disruption mutant of OG1RF; Adh2 Fusr Kanr Rifr This study
E. coli
DH5a E. coli host strain used for routine cloning Stratagene
INVaF9 E. coli host strain for cloning of PCR products Invitrogen
LMG194 E. coli strain for expression of recombinant proteins Invitrogen
TX5252 INVaF9 (pTEX5252); Ampr Kanr This study
TX5253 DH5a (pTEX5253); Kanr This study
TX5254 LMG194 (pTEX5254); Ampr This study
Plasmids
pTEX4577 Derived from pBluescript SK2, used for insertion disruption mutagenesis in enterococci 28
pBAD/HisA Expression vector Invitrogen
pTEX5252 1,003-bp intragenic ace PCR product cloned into pCR2.1 (TA cloning vector) This study
pTEX5253 1,100-bp XhoI-KpnI intragenic ace fragment from pTEX5252 cloned into pTEX4577 This study
pTEX5254 1,008-bp OG1RF ace (coding for complete A domain) cloned into pBAD/HisA expression vector This study
a Adh1, adherence to CI, CIV, and LN after growth at 46°C; Adh2, markedly reduced adherence to CI, CIV, and LN; Ampr, ampicillin resistant; Fusr, fusidic acid
resistant; Kanr, kanamycin resistant; Rifr, rifampin resistant.
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pellet was lysed by sonication in denaturing lysis buffer (8 M urea, 0.1 M
NaH2PO4, 0.01 M Tris-HCl [pH 8.0]) containing 5 mM imidazole, and the
supernatant was purified by metal chelation (Ni21) chromatography. The bound
proteins were washed with a mixture of 8 M urea, 0.1 M NaH2PO4, and 0.01 M
Tris-HCl (pH 6.3) and neutralized with renaturing buffer (50 mM Tris-HCl, 50
mM NaCl, 50 mM NaH2PO4 [pH 8.0]); after washing with renaturing buffer
containing 20 to 40 mM imidazole, the recombinant protein was eluted with a
linear gradient of 50 to 400 mM imidazole in renaturing buffer, and the fractions
were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Fractions containing eluted recombinant Ace A were pooled,
dialyzed against 25 mM Tris-HCl (pH 8.0), concentrated by lyophilization, and
repurified by metal chelation (Ni21) chromatography. Purified recombinant Ace
A protein showed a single band on SDS-PAGE.
Production of rabbit polyclonal serum. After verifying a single reacting band
of His-tagged recombinant Ace A on a Western blot probed with anti-His
(penta) antibodies (Qiagen, Inc.), this protein was used to raise polyclonal
antibodies by immunization of rabbits at Bethyl Laboratories, Inc. (Montgomery,
Tex.) and stored at 270°C. Antibody titers of sera were determined by enzyme-
linked immunosorbent assay (ELISA) with preimmune serum as a control.
Protein extraction and Western blotting. Protein extracts from E. faecalis
OG1RF were prepared by using mutanolysin (Sigma Chemical Co.). E. faecalis
OG1RF cells grown at 37 and 46°C were washed and resuspended in 1/10 volume
of 0.02 M Tris-HCl (pH 7.0)–0.01 M MgSO4 buffer containing 100 mM phenyl-
methylsulfonyl fluoride (PMSF). Mutanolysin was added to a final concentration
of 5 U/1 OD600 of cells and incubated at 37°C for 1 h in a rotating shaker. The
supernatant collected after centrifugation at 11,750 3 g for 15 min was concen-
trated by lyophilization. Protein concentrations were estimated by bicinchoninic
acid assay (Pierce, Rockford, Ill.). Mutanolysin extracts from the E. faecalis
OG1RF wild type and Ace insertion mutant (TX5256) were electrophoresed on
4 to 12% NuPAGE Bis-Tris gels (NOVEX) under reducing conditions in MOPS
(3-[N-morpholino]propanesulfonic acid) buffer, and transferred to a polyvinyli-
dene difluoride (PVDF) membrane. Electrophoresis and transfer were carried
out according to the protocol supplied by NOVEX. Membranes were then
incubated with either anti-Ace A polyclonal antiserum or preimmune serum
(antibody I) followed by protein A-horseradish peroxidase conjugate (antibody
II), and developed with 4-chloronaphthol in the presence of H2O2.
Far-Western blot assay. Mutanolysin-PMSF extracts from the parental E.
faecalis OG1RF and its ace insertion mutant (TX5256) were electrophoresed on
4 to 12% NuPAGE Bis-Tris gel (NOVEX) under nonreducing conditions in
MOPS buffer and transferred to a PVDF membrane. After overnight renatur-
ation in blocking buffer, the membrane was further incubated with 10 mg of CIV
per ml for about 16 h at 4°C with gentle shaking. Bound CIV on Western blots
was detected with anti-CIV monoclonal antibodies (Sigma Chemical Co.) fol-
lowed by horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G
(IgG) antibodies (Life Technologies, Inc.), and developed with 4-chloronaphthol
in the presence of H2O2.
Elution of antibodies specific to Ace. Because the Ace immune serum previ-
ously described (24) was found to react with several bands, we eluted Ace
A-specific antibodies from anti-Ace (OG1RF) rabbit immune serum by the
method described below and used in the adherence inhibition assay. Recombi-
nant Ace A protein was electrophoresed on 10% NuPAGE Bis-Tris gels
(NOVEX) and transferred to a PVDF membrane. Membranes were blocked
with 5% skim milk and incubated with polyclonal serum raised against recom-
binant Ace A of OG1RF. Following visualization of the antibodies bound to Ace
on a cut strip by the procedure described in the previous section, the area
containing the antigen-anti-Ace antibody complex was excised and incubated
with 10 ml of 100 mM glycine (pH 2.5) for 15 min at room temperature to elute
Ace-specific antibodies. After neutralization with 1 ml of 1 M Tris (pH 8.0), the
solution was transferred to a clean tube and stored at 220°C until use (7).
IgG purification and inhibition of adherence. IgGs were purified from both
preimmune rabbit serum and polyclonal immune rabbit serum raised against
recombinant Ace by affinity column chromatography with the Immunopure (G)
IgG purification kit as per the supplied protocol (Pierce). Labeled bacteria were
incubated with various concentrations of either preimmune rabbit IgGs or anti-
Ace A IgGs for 1 h at 37°C and then centrifuged at 2,800 3 g followed by
resuspension in PBS with 0.1% Tween 80 and 0.1% BSA to remove excess
unbound IgGs, prior to addition of labeled cells to the ECM-coated wells in
adherence assay described earlier. Eluted Ace-specific antibodies were also used
in the inhibition assay.
Binding of recombinant Ace to collagens and LN. Microtiter plates were
coated with 10 mg of ECM proteins or BSA in 100 ml of PBS and allowed to
incubate overnight at 4°C. Wells were washed five times with PBST (PBS with
0.01% Tween 20). After blocking wells with 5% BSA, wells were again washed.
Various concentrations of recombinant Ace A (1 to 200 mg/100 ml) in PBS with
0.1% BSA were added to the wells and incubated at 37°C. After 4 h, unbound
protein was removed by washing with PBST. Bound proteins were detected by
penta-His monoclonal antibodies (Qiagen, Inc.) that recognize the His tag of the
recombinant Ace A protein, followed by horseradish peroxidase-conjugated goat
anti-mouse IgG antibodies (Life Technologies, Inc.). Relative binding was mea-
sured by monitoring A450 following the addition of 3, 39, 5, 59-tetramethylbenzi-
dine and H2O2. In a parallel set of experiments, CI-, CIV-, and LN-precoated
wells were digested with collagenase VII (Sigma Chemical Co.) before incuba-
tion with recombinant Ace A.
RESULTS
Construction of an ace disruption mutation and stability.
Following electroporation of OG1RF with the suicide vector
pTEX5253 and selection on kanamycin, 14 recombinant
OG1RF colonies were recovered. DNA from three kanamycin-
resistant OG1RF derivative colonies was digested with NotI or
SmaI, followed by PFGE; hybridization with an ace probe,
prepared by amplification with the AceF2 and AceR3 primers,
showed two ace hybridizing bands (as expected for insertion
duplication mutants, since there are single NotI and SmaI
restriction sites in pTEX5253). OG1RF processed the same
way showed a single hybridizing fragment. One of these colo-
nies was designated as TX5256. The correct insertion, resulting
from integration of pTEX5253, was also verified by sequencing
of the PCR product amplified from TX5256 genomic DNA by
using AceF1 and T7 primers and was found to have occurred
at nucleotide 1101.
All colonies of TX5256 tested after passing through multiple
generations without antibiotic selection retained the ability to
grow on BHI agar supplemented with 2,000 mg of kanamycin
per ml, indicating the stability of this mutation.
Adherence of the OG1RF ace mutant (OG1RF ace::
pTEX5253). Adherence of OG1RF and the mutant TX5256 to
ECM proteins (CI, CIV, and LN) was tested. The ace mutant
grown at 46°C showed a 6.4-fold decrease in percentage of
binding to CI (from 21.1% to 3.3%) when compared to
OG1RF. Similarly, the ace mutant grown at 46°C showed a
substantial decrease in adherence to CIV (27.4-fold decrease
relative to OG1RF) and LN (32.9-fold decrease relative to
OG1RF) (Fig. 1). This reduced adherence was also found in
two other ace-disrupted kanamycin-resistant colonies tested
(data not shown).
Western analysis of mutanolysin preparations of E. faecalis
OG1RF and the OG1RF ace mutant. Anti-Ace A polyclonal
immune rabbit serum reacted with a single ;105-kDa band of
mutanolysin-PMSF extracts prepared from 46°C-grown
OG1RF, whereas no bands were detected from mutanolysin-
PMSF extracts of 37°C-grown OG1RF (Fig. 2A). The apparent
observed molecular mass is higher than predicted (calculated
FIG. 1. Adherence of E. faecalis OG1RF and TX5256 (OG1RF ace::
pTEX5253) to immobilized CI, CIV, LN, and BSA. Adherence was tested in
wells coated with 1 mg of ECM proteins (see text). Bars represent the mean
percentages of cells bound 6 standard deviations for six wells. Results are
representative of three independent experiments. BSA was used as a negative
control.
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based on the sequence described in the companion paper [19]),
perhaps due to the acidic nature of the Ace protein (24), which
has a pI of 4.2 as calculated from the amino acid sequence. The
OG1RF ace mutant (TX5256) grown at 46°C demonstrated
loss of the ;105-kDa immunoreactive protein band seen in
OG1RF grown at 46°C (Fig. 2B).
Influence of anti-Ace IgGs on adherence of E. faecalis
OG1RF to ECM proteins. We have previously reported inhi-
bition of adherence of a 46°C-grown E. faecalis OG1RF gelE
mutant (28) to CI by IgGs purified from E. faecalis EF1 anti-
Ace A antibodies (24). However, that serum reacted with sev-
eral bands on Western blots. Using IgGs that were purified
from E. faecalis OG1RF anti-Ace A polyclonal immune serum,
we tested the influence of anti-Ace IgGs on adherence of
OG1RF to CIV and LN as well as to CI. Using 0.001 to 100 mg
of either purified preimmune IgGs or purified anti-Ace IgGs
per ml, inhibition of adherence was tested. Preincubation with
as little as 1 mg of anti-Ace IgGs per ml considerably inhibited
adherence to CIV and LN, in addition to CI, whereas preim-
mune serum had no effect on adherence over the range of
concentrations tested (Table 2). Antibodies eluted from re-
combinant Ace A were also tested in the adherence inhibition
assay. As shown in Fig. 3, eluted antibodies at a 1-mg/ml con-
centration eliminated 46°C-grown OG1RF adherence to the
three ECM proteins, CI, CIV, and LN (28- to 37-fold decrease
relative to OG1RF).
We also examined the ability of these anti-Ace A IgGs
(purified from rabbit polyclonal immune serum raised against
OG1RF-derived recombinant Ace A) to inhibit adherence of
two clinical E. faecalis strains, V583 and MC02152, to CI, CIV,
and LN that showed conditional binding at 46°C. Preincuba-
tion of these strains with anti-Ace A IgGs at a 20-mg/ml con-
centration inhibited adherence to CI, CIV, and LN; relative to
preimmune serum, adherence decreased by about 8.5- to 13.4-
fold as shown in Table 3. Purified IgGs from preimmune serum
had no effect on adherence at this concentration.
CIV interaction with Ace by far-Western blotting. We used
far-Western analysis and examined CIV’s interaction with the
;105-kDa Ace protein to determine the direct association of
CIV with Ace. Probing of mutanolysin-PMSF extracts (pre-
pared from 46°C-grown OG1RF) on a Western blot with CIV,
FIG. 2. Western blots of E. faecalis OG1RF and its ace mutant, TX5256
(OG1RF ace::pTEX5253). (A) Mutanolysin surface preparations probed with
anti-Ace A polyclonal immune serum. Lanes: 1 and 2, protein extracts from
37°C- and 46°C-grown OG1RF, respectively; 3, molecular mass standards. (B)
Mutanolysin surface preparations of 46°C-grown E. faecalis OG1RF and
TX5256. Lanes: 1 and 2, OG1RF and TX5256 protein extracts, respectively,
probed with rabbit preimmune serum; 3 and 4, OG1RF and TX5256 protein
extracts, respectively, probed with anti-Ace A polyclonal immune serum; and 5,
molecular mass standards.
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followed by detection with anti-CIV monoclonal antibodies,
identified a single ;105-kDa protein band, whereas no band
was detected from mutanolysin extracts of the OG1RF ace
mutant (Fig. 4).
Binding of recombinant Ace A domain to ECM proteins.
The results from an ELISA demonstrating the binding of re-
combinant Ace A to immobilized CI, CIV, and LN are shown
in Fig. 5. Binding of recombinant Ace protein to the collagens
and laminin was found to be concentration dependent and
exhibited saturation kinetics. Fibrinogen, to which none of the
E. faecalis isolates bound in our assay (39), was used as a
control. The percentage of Ace bound to fibrinogen was the
same as to BSA at all of the concentrations tested (data not
shown). As evident from Fig. 5, binding of Ace A to CIV was
slightly greater than its binding to CI and LN. The results from
collagenase VII-treated wells showed that the binding of re-
combinant Ace A to CI and CIV was markedly reduced after
collagenase treatment, whereas LN-coated wells were unaf-
fected by collagenase treatment, indicating that the LN was not
substantially contaminated by collagen (data not shown).
DISCUSSION
We previously showed that the majority of E. faecalis isolates
adhered, after growth at 46°C, to CI, CIV, and LN (39). An
examination of the adherence process revealed that (i) E. fae-
calis strain OG1RF adherence was dependent on the amounts
of CI, CIV, and LN in the substrates; (ii) OG1RF adherence to
ECM proteins was inhibited after preincubation of the bacteria
with soluble ECM proteins; (iii) trypsin treatment of the bac-
teria rendered the cells nonadhesive; (iv) digestion of the CI
and CIV substrates with collagenase destroyed their ability to
support adhesion of strain OG1RF, whereas bacteria still ad-
hered to collagenase-digested LN substrate; and (v) scanning
electron microscopy of E. faecalis OG1RF adhered to LN-
coated wells showed single cells evenly distributed over the
substrate (39). We recently identified a gene, ace, in the E.
faecalis strain V583 partial genome database that encodes a
protein with a structural organization similar to the collagen
binding microbial surface component recognizing adhesive
matrix molecules (MSCRAMM), Cna, from S. aureus. Both
proteins contain features characteristic of cell wall-anchored
proteins at the C terminus preceded by a region composed of
B repeats and an N-terminal A region. The A region of Cna
contains the collagen binding domain, which has a b-barrel
structure as revealed by X-ray analysis of protein crystals (36).
One of the b-sheets contains a “trench” that was identified as
a putative collagen binding site. Computational docking exper-
iments showed that the binding trench could accommodate the
rope-like collagen structure (23, 36). The A region of Ace has
significant sequence similarity to the corresponding domain of
Cna. We therefore expressed a recombinant form of the Ace A
region and showed by circular dichroism spectroscopy that the
secondary structures of the Ace and Cna A regions are very
similar (24). In fact, computational analysis suggested that the
putative ligand binding domain of Ace adopts a structure very
similar to that determined for the corresponding domain of
Cna with a predicted binding trench. Furthermore, the recom-
binant Ace A region bound CI, and antibodies raised against
FIG. 3. Inhibition of adherence of E. faecalis OG1RF to ECM proteins by
eluted Ace A-specific antibodies. These antibodies were eluted with recombinant
Ace A on the Western blot and were from anti-Ace A polyclonal immune serum.
Labeled bacteria were incubated with 1 mg of eluted Ace-specific antibodies per
ml for 1 h at 37°C. Adherence was tested in wells coated with 1 mg of ECM
proteins (see text). Bars represent the mean percentages of cells bound 6
standard deviations for four wells. Results are representative of two independent
experiments.
TABLE 3. Inhibition of adherence of 46°C-grown E. faecalis clinical isolates V583 and MC02152 to ECM proteins
by IgGs (20 mg/ml) purified from anti-Ace A (OG1RF-derived) rabbit immune serum
ECM
% of cells bounda
V583 MC02152
No IgG PI Anti-Ace No IgG PI Anti-Ace
CI 29.2 6 1.87 28.1 6 2.84 3.2 6 0.17 26.0 6 1.61 24.4 6 1.31 2.9 6 0.46
CIV 38.1 6 8.66 33.6 6 6.81 2.5 6 0.17 27.7 6 0.39 26.5 6 1.84 2.3 6 0.13
LN 29.4 6 1.96 27.6 6 3.53 2.7 6 0.78 26.7 6 1.22 23.5 6 0.76 1.9 6 0.52
BSA 0.7 6 0.10 0.6 6 0.07 0.6 6 0.01 0.6 6 0.12 0.5 6 0.19 0.6 6 0.17
a Values are mean percentages of cells bound 6 standard deviations for six wells. Results are representative of three independent experiments. PI, IgGs purified from
preimmune rabbit serum; Anti-Ace, IgGs purified from polyclonal anti-Ace A rabbit immune serum.
FIG. 4. Far-Western blot assay of extracts of 46°C-grown E. faecalis OG1RF
and its ace mutant TX5256. OG1RF and TX5256 extracts on PVDF membrane
were probed with 10 mg of CIV per ml, and bound CIV was detected with
anti-CIV monoclonal antibodies. Lanes: 1, CIV (positive control); 2 and 3,
OG1RF and TX5256 mutanolysin extracts; and 4, molecular mass standards.
5222 NALLAPAREDDY ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
the recombinant protein inhibited adherence of E. faecalis to
CI substrate (24).
In the current study, we have characterized the E. faecalis-
specific (R. W. Duh, K. V. Singh, K. Malathum, and B. E.
Murray, submitted for publication) ace gene from strain
OG1RF and found that an OG1RF ace mutant showed mark-
edly reduced binding not only to immobilized CI, but also to
CIV and LN, raising the possibility that the same MSCRAMM
is responsible for adherence to the three ECM proteins. How-
ever, since this mutant was generated by a chromosomal in-
sertion, the possibility remains that the inserted plasmid may
have had a polar effect on downstream genes that are respon-
sible for some of the observed effect.
To detect the Ace protein in E. faecalis OG1RF, we raised
polyclonal antibodies against recombinant Ace A of OG1RF
that has been expressed in E. coli. These anti-Ace A antibodies
detected an ;105-kDa protein in 46°C-grown OG1RF, but not
in 37°C-grown OG1RF; the OG1RF ace mutant was found to
lack the ;105-kDa protein. Detection of this anti-Ace reactive
band in 46°C-grown OG1RF mutanolysin extracts, but not in
37°C-grown OG1RF, correlates with the previously reported
conditional (growth at 46°C) binding (39). We have also se-
quenced the complete ace gene from OG1RF (19). The de-
duced amino acid sequence of OG1RF Ace adhesin predicts a
75.6-kDa protein, which is ;30 kDa smaller than the observed
molecular size on the Western blot. Similar results were found
for Ace proteins of the other E. faecalis strains studied in the
companion paper (19) as well as for E. faecalis EF1 and EF2
(24). This difference may be due to the highly acidic nature of
the Ace protein (24). Another possibility is that the difference
in migration might be due to association of Ace with pepti-
doglycan, although mutanolysin treatment is known to free at
least some proteins from peptidoglycan (8). However, several
lines of evidence strongly indicate that the protein identified in
mutanolysin-PMSF extracts is indeed the ace gene product.
The evidence includes the following: (i) anti-Ace A polyclonal
antibodies reacted with a single ;105-kDa band in mutanoly-
sin extracts prepared from 46°C-grown E. faecalis OG1RF; (ii)
preimmune serum did not react with any band in these ex-
tracts; and (iii) there was loss of the ;105-kDa protein band in
the ace insertion mutant. In a companion paper, we also report
that protein size variation among various E. faecalis strains
corresponds to the number of B repeats (19).
To confirm the direct involvement of Ace, and not possible
downstream gene products, in 46°C-evoked adherence of E.
faecalis to CI, CIV, and LN, we tested the ability of anti-Ace A
IgGs to inhibit binding of E. faecalis OG1RF to these immo-
bilized ECM proteins. The inhibition of the adherence of 46°C-
grown OG1RF to CI, CIV, and LN by anti-Ace A IgGs as well
as by eluted Ace-specific antibodies provides evidence that the
;105-kDa protein of OG1RF is the adhesin that mediates
binding to these three ECM proteins. We also tested the ability
of these IgGs to block adherence of the two clinical strains
V583 and MC02152 after growth at 46°C. The inhibited ad-
herence to CI, CIV, and LN by anti-Ace IgGs in these two
strains further corroborates the involvement of Ace A in
strains that showed conditional adherence. We confirmed the
CIV affinity to the ;105-kDa OG1RF Ace protein by using a
far-Western blot and then extended this result to test the
binding ability of the recombinant Ace A domain to CI, CIV,
and LN in an ELISA. In the ELISAs, OG1RF-derived recom-
binant Ace A protein bound to CI as well as to CIV and LN.
These ELISA results implicate the A domain of Ace in binding
to CI, CIV, and LN. It is tempting to speculate that the pro-
posed trench on the Ace A domain that has been implicated in
binding the triple helix collagen structure (Y. Xu, R. T. Owens
and M. Ho¨o¨k, unpublished results) is also responsible for bind-
ing the rigid triple helix structure of the LN long arm. By
analogy, the collagen binding integrins a1b1 and a2b1, both of
which both contain a trench in the binding domain, have been
shown to bind LN in addition to several types of collagens,
including CI and CIV (3, 21, 32).
Similar to the E. faecalis Ace adhesin, other adhesins have
been reported to bind to different ECM proteins. The plasmid-
encoded outer membrane protein YadA of Yersinia enteroco-
litica has been shown to bind to several types of collagens (27),
LN (4, 29), and fibronectin (37). A 150-kDa fibrinogen binding
adhesin of Porphyromonas (Bacteroides) gingivalis also recog-
nized fibronectin (9, 10). Switalski et al. (34) showed that the
collagen-binding MSCRAMM from S. aureus (later identified
as Cna) recognizes many types of collagens and McGavin et al.
(15) identified an S. aureus surface protein that could bind with
broad specificity to several ECM proteins, including fibrino-
gen, fibronectin, and vitronectin.
In conclusion, the results from the constructed OG1RF ace
mutant and the inhibition of binding of OG1RF and of two
clinical isolates to all three ECM proteins by anti-Ace A anti-
bodies demonstrate that the A domain of Ace mediates ad-
herence of E. faecalis to CIV and LN in addition to CI. Further
supporting evidence for Ace A-mediated binding was obtained
from the CIV far-Western analysis and the ELISAs showing
binding of recombinant Ace A to both collagens and LN.
Additional studies will be needed to determine what if any
contribution ace may make to the ability of E. faecalis to
colonize and/or cause infection in humans.
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